BioCatalyst

CagriSema (Cagrilintide B and Semaglutide I) — catalyst calendar

1 verified catalyst event(s) referencing CagriSema (Cagrilintide B and Semaglutide I), each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-21
in 2mo
ESTIMATED
 READOUT
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in
Phase 2 · Diabetes Mellitus, Type 2, Diabetic Peripheral Neuropathy
 NVO NOVO NORDISK A S CagriSema (Cagrilintide B and Semaglutid ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.